Search Results 11-20 of 7667 for Strontium-89
Previous treatment with any of the following within 6 months of randomization: Strontium-89, Samarium-153, Rhenium-186, Rhenium-188, Radium-223, hemi-body
Strontium-89, Samarium-153, Rhenium-186, Rhenium-188, Radium-223, hemi-body irradiation. Previous PSMA-targeted radioligand therapy is not allowed 5 ...
Systemic strontium-89, samarium-153, rhenium-186, or rhenium-188 for bone metastases within 24 weeks prior to initiation of study treatment; Spinal ...
Strontium-89;; Samarium-153;; Rhenium-186;; Rhenium-188;; Radium-223;; Hemi-body irradiation;; Previous PSMA-targeted radioligand therapy is not allowed. Any ...
Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, ...
Patients who have received wide field radiotherapy (including therapeutic radioisotopes such as strontium 89) ≤ 4 weeks or limited field radiation for ...
A doctor or other trained health professional will give you or your child this medicine. Depending on your medical problem, this medicine is given as a shot ...
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need ...
Short term ketoconazole treatment (< 28 days) is permitted. 3. Radiopharmaceutical agents (e.g., Strontium-89, PSMA-targeted radioligand therapy). 4 ...
Check with your doctor or nurse immediately if any of the following side effects occur: Less common. Confusion; dizziness; fast heartbeat; trouble breathing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.